Mesoblast Limited
MESO · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1,315,287 | $668,987 | $655,102 | $303,125 |
| - Cash | $161,158 | $62,563 | $70,920 | $60,034 |
| + Debt | $128,157 | $118,923 | $116,495 | $106,905 |
| Enterprise Value | $1,282,286 | $725,347 | $700,677 | $349,996 |
| Revenue | $17,198 | $5,902 | $7,501 | $10,211 |
| % Growth | 191.4% | -21.3% | -26.5% | – |
| Gross Profit | $12,068 | -$35,168 | -$47,421 | -$53,361 |
| % Margin | 70.2% | -595.9% | -632.2% | -522.6% |
| EBITDA | -$73,659 | -$56,077 | -$58,550 | -$76,573 |
| % Margin | -428.3% | -950.1% | -780.6% | -749.9% |
| Net Income | -$102,142 | -$87,956 | -$81,889 | -$91,347 |
| % Margin | -593.9% | -1,490.3% | -1,091.7% | -894.6% |
| EPS Diluted | -0.84 | -0.89 | -0.98 | -1.3 |
| % Growth | 5.6% | 9.2% | 24.6% | – |
| Operating Cash Flow | -$49,954 | -$48,458 | -$63,269 | -$65,782 |
| Capital Expenditures | -$730 | -$331 | -$314 | -$232 |
| Free Cash Flow | -$50,684 | -$48,789 | -$63,583 | -$66,014 |